The New Decisions of the SGK Are in the Official Gazette: Delete Reimbursement Requirements for Medicines From Scratch
11 Articles
11 Articles
The SSR has made sweeping changes to the rules for the delivery and financing of health services. The new regulation updated the provisions for the reimbursement of treatment and transfer expenses for organ and tissue transplants, while the conditions for reimbursement of certain transplants and cancer drugs were redefined.
Minister of Labor and Social Security Vedat Işıkhan announced that two drugs used in the treatment of early-stage breast cancer and a rare disease affecting the optic nerve have been included in the reimbursement coverage. The regulation also covers advanced surgical procedures for newborn and pediatric patients...
The Social Security Institution (SGK) has made significant changes to the Health Application Regulation. Payment conditions have been updated in many areas, from organ transplants to cancer drugs, from procedure points to bone marrow transplants. While the reimbursement conditions for some drugs have been tightened, new restrictions have been introduced for some treatments.
Minister of Labor and Social Security Vedat Işıkhan announced that the Social Security Institution (SGK) has made new regulations regarding reimbursement. Accordingly, two drugs used in the treatment of early-stage breast cancer and a rare disease affecting the optic nerve have been added to the reimbursement list, while advanced surgical procedures performed on newborns and children have also been included in the coverage. 🚆
The Social Security Institution (SGK) has made fundamental changes to the Health Application Communiqué (SUT) with a decision published in the Official Gazette dated October 2, 2026.
New regulations have been introduced in the SGK (Social Security Institution) Health Application Circular. Minister Vedat Işıkhan announced that two drugs used in the treatment of early-stage breast cancer and a rare disease involving the optic nerve have been included in the reimbursement coverage.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
